Delivery Order SPE2DB25D3006-SPE2DB25FXHSQ

Award Date 4/3/25
Potential Completion Date 4/4/25
Potential Value $8.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ORENCIA 125 MG/ML SYRINGEML, a specialty pharmaceutical product, with a ceiling value of $24,161.79 and a performance period through March 2025. The contract was awarded as an unrestricted competition, without any set-aside designation. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,002.90, is a delivery order for the supply of ORENCIA 125 MG/ML SYRINGEML. It is a firm fixed price contract with an ultimate completion date of April 2, 2025. The contract is not associated with a set-aside program. It is part of a larger Indefinite Delivery Contract (IDC) that...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $9,926.49 firm fixed-price contract is for the supply of ORENCIA 125 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract has an ultimate completion date of April 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ORENCIA 125 MG/ML SYRINGEML, a pharmaceutical product, with a ceiling value of $10,470.71. The contract is a firm fixed-price delivery order without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $26,990.98, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of ORENCIA 125 MG/ML SYRINGEML, a specialty pharmaceutical product. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ORENCIA 125 MG/ML SYRINGE, a specialty medication, to support military healthcare programs. The contract has a ceiling value of $3,927.41 and is a firm fixed price contract with a period of performance through February 4, 2025. The contract is not designated as a set-aside...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $15,812.07, is for the delivery of ORENCIA CL 125MG/ML 4S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of July 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This is a $27,474.20 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 125 mg/mL ORENCIA syringes, with a period of performance through February 7, 2025. This order is placed against AmerisourceBergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which serves as the primary vehicle for providing a comprehensive...
This federal contract award, valued at $8,538.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of ORENCIA 125 MG/ML SYRINGEML, a specialty medication. The contract has an ultimate completion date of February 13, 2025 and is a firm fixed-price arrangement. It is not designated as a set-aside contract, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,344.02 firm-fixed-price delivery order is for the supply of ORENCIA 125 MG/ML syringes. The contract has an ultimate completion date of January 14, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
  • SPE2DB25D3006
    Indefinite Delivery Contract
  • SPE2DB25D3006-SPE2DB25FXHSQ
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ORENCIA 125 MG/ML SYRINGEML, a specialty medication, with a ceiling value of $8,070.62 and a period of performance through April 4, 2025.

The contract is not designated as a set-aside award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order contract is likely part of the broader IDC framework, enabling efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 7/6/25, 12:43 AM